PKM and hepatocellular carcinoma: The deacetylation of K62 promotes the nuclear translocation of PKM2 and binding to β-catenin, thereby promoting CCND1 gene transcription and growth of HCC cells.[20] Therefore, these results suggest that PKM2/β-catenin signaling may become a target for the treatment of HCC.